CANbridge Pharmaceuticals raised $43M Series E venture round, led by Cathy Chen.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Public | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$214M
Top Valuation
-
CANbridge Pharmaceuticals raised $43M in a Series E round.
The round was announced on 12/01/20.
The round was led by Cathy Chen.